Larvol Delta - Atossa-Therapeutics-Announces-Ovarian-Cancer-Patient-has-Begun-Treatment-with-Oral-Endoxifen-under-FDAs-Expanded-Access-Pathway

endoxifen - Atossa Therap

https://www.globenewswire.com/news-release/2021/04/08/2206823/0/en/Atossa-Therapeutics-Announces-Ovarian-Cancer-Patient-has-Begun-Treatment-with-Oral-Endoxifen-under-FDA-s-Expanded-Access-Pathway.html

Apr 8, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next